Challenges in glioblastoma research: focus on the tumor microenvironment

A Bikfalvi, CA da Costa, T Avril, JV Barnier, L Bauchet… - Trends in cancer, 2023 - cell.com
Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive
molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has …

Immune checkpoint inhibitors in human glioma microenvironment

A Ghouzlani, S Kandoussi, M Tall, KP Reddy… - Frontiers in …, 2021 - frontiersin.org
Gliomas are the most common primary brain tumors in adults. Despite the fact that they are
relatively rare, they cause significant morbidity and mortality. High-grade gliomas or …

The endocannabinoid system: A target for cancer treatment

C Laezza, C Pagano, G Navarra, O Pastorino… - International journal of …, 2020 - mdpi.com
In recent years, the endocannabinoid system has received great interest as a potential
therapeutic target in numerous pathological conditions. Cannabinoids have shown an …

Targeting RTK-PI3K-mTOR axis in gliomas: An update

M Colardo, M Segatto, S Di Bartolomeo - International Journal of …, 2021 - mdpi.com
Gliomas are the most common and challenging malignancies of the central nervous system
(CNS), due to their infiltrative nature, tendency to recurrence, and poor response to …

Patient-derived glioma models: from patients to dish to animals

CC da Hora, MW Schweiger, T Wurdinger, BA Tannous - Cells, 2019 - mdpi.com
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults
associated with a poor survival. Current standard of care consists of surgical resection …

Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets

JI Erices, C Bizama, I Niechi, D Uribe… - International journal of …, 2023 - mdpi.com
Glioblastoma (GBM) is the most common and malignant primary brain cancer in adults.
Without treatment the mean patient survival is approximately 6 months, which can be …

From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer

E Gonzales-Aloy, A Ahmed-Cox, M Tsoli… - Advanced Drug Delivery …, 2023 - Elsevier
Brain cancer remains the deadliest cancer. The blood–brain barrier (BBB) is impenetrable to
most drugs and is a complex 3D network of multiple cell types including endothelial cells …

In vitro glioblastoma models: A journey into the third dimension

M Paolillo, S Comincini, S Schinelli - Cancers, 2021 - mdpi.com
Simple Summary In this review, the thorny issue of glioblastoma models is addressed, with a
focus on 3D in vitro models. In the first part of the manuscript, glioblastoma features and …

Cannabinoids in glioblastoma therapy: new applications for old drugs

CA Dumitru, IE Sandalcioglu, M Karsak - Frontiers in molecular …, 2018 - frontiersin.org
Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of
solid cancer overall. Despite aggressive therapeutic approaches consisting of maximum …

Engineering three-dimensional tumor models to study glioma cancer stem cells and tumor microenvironment

H Ruiz-Garcia, K Alvarado-Estrada… - Frontiers in Cellular …, 2020 - frontiersin.org
Glioblastoma (GBM) is the most common and devastating primary brain tumor, leading to a
uniform fatality after diagnosis. A major difficulty in eradicating GBM is the presence of …